Home Lisa Jenkins VanLuvanee, Ph.D. Randy Goodman, Ph.D., MHA, FACHE, PMP, BCMAS Michelle Byrne, BME, RAC Josh Eldridge, Ph.D. Dana Blue, M.S. William (Bill) Hodnick, Ph.D., DABT Blog & Insights Publications Resource Center Facet Life Sciences Recognized in Top 10 Regulatory Services Companies for 2023 Rare Disease Causes We Champion Facet Life Sciences Quarterly Update Q1 – 2023 Events – SNMMI 2023 Therapeutics Conference Events – AusBiotech Conference 2023 Facet Life Sciences Recognizes Michelle Byrne’s Achievements Facet Life Sciences Quarterly Update Q3 – 2023 FDA Round Up – Q3 2023 Partner News – Q3 2023 Facet Life Sciences Recognizes Dr. Jason Mercer’s Achievements From The Corner Office Spotlight On – Q4 2023 Facet By The Numbers – Q4 2023 New Services: Strategic Commercialization Support Facet Life Sciences Recognized in Top 10 Regulatory Services Companies for 2024 Facet Life Sciences Quarterly Update Q1 – 2024 Spotlight On – Q1 2024 Industry Focus – Q1 2024 Go Team! – Q1 2024 Spotlight On Rare Disease Development – Q1 2024 Did You Know – Q1 2024 FDA Round Up – Q1 2024 Facet By The Numbers – Q1 2024 Industry Focus Q2-2024: Chevron Deference Industry Focus Q2 2024 – FDA Final Guidance for Lab Developed Tests Industry Focus Q2-2024: Chinese and Indian Biotech Update Spotlight On Rare Disease Development – Q2 2024 – New RD Hub Spotlight On Rare Disease Development – Q2 2024 – START Pilot Program Updates ICYMI – Q2 2024 – PET CMC Coalition ICYMI – Q2 2024 – FDLI Annual Conference ICYMI – Q2 2024 – Market Access Society of America Symposium ICYMI – Q2 2024 – Psychedelic Therapeutics & Drug Development Conference ICYMI – Q2 2024 – SNMMI ICYMI – Q2 2024 – SNMMI’s Mars Shot Go Team! – Q2 2024 Facet By The Numbers – Q2 2024 Facet Life Sciences Quarterly Update Q2 – 2024 Facet Life Sciences Announces Partnership with Nucleus as Official Regulatory Partner Facet is Proud to be a 2025 SNMMI Mars Shot Research Fund Donor Facet’s Dana Blue Returns to AMWA Regulatory Writing Subcommittee for 2026